Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Renessans Sachet is a multi-ingredient hepatoprotective dietary supplement developed and marketed by MTI Medical. It is formulated as an oral sachet containing a combination of milk thistle (silymarin), choline, L-ornithine, B vitamins, and iodine. The product is designed to provide hepatic support and liver protection through several metabolic pathways. Silymarin acts as an antioxidant and anti-inflammatory agent to stabilize hepatic cell membranes, while choline and L-ornithine support lipid metabolism and the urea cycle, respectively, aiding in the detoxification and processing of metabolic byproducts. It is primarily indicated for liver health maintenance and nutritional support in hepatic conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Renessans Sachet.